Skip to content

Clinical trials

Phase 2 Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 2 Country / region: United States Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20071
20083
20093
20102
20112
20131
20143
20151
20163
20175
20184
20191
20201
20213
20222
20233
20241
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting9
Terminated6
Withdrawn4
Suspended2
Enrolling by invitation2
Unknown status1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics4
Alkahest, Inc.3
Northwestern University3
U.S. Army Medical Research and Development Command3
Flex Pharma, Inc.2
GlaxoSmithKline2
Knopp Biosciences2
Novartis2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases55
Central Nervous System Diseases28
Brain Diseases22
Neurodegenerative Diseases17
Mental Disorders16
Dementia10
Neurologic Manifestations10
Alzheimer Disease9
Neurocognitive Disorders8
Neuromuscular Diseases7

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.